This inventor holds 1 USPTO granted patent. Top assignee: Sanofi-A Ventis Deutschland Gmbh. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: The Innovative Mind of Dirk Hoerstermann
Introduction
Dirk Hoerstermann, an accomplished inventor based in Paris, France, has made significant contributions to the field of medicinal chemistry. His work primarily focuses on developing polymorphic forms of compounds that have potential applications in the pharmaceutical industry.
Latest Patents
Dirk holds a notable patent titled "Crystalline phases of 2'-{[2-(4-methoxy-phenyl)-acetylamino]-methyl}-biphenyl-2-carboxylic acid (2-pyridin-3-yl-ethyl)-amide." This invention emphasizes the preparation of polymorphic forms and solvates of this compound. The research outlines processes for their preparation and their use in creating medicaments that could potentially enhance patient outcomes.
Career Highlights
Throughout his career, Dirk has been associated with prominent companies in the pharmaceutical sector. He currently works at Sanofi-Aventis Deutschland GmbH, where he continues to drive innovation and contribute to groundbreaking research aimed at improving health.
Collaborations
Dirk has collaborated with talented coworkers, including Norbert Nagel and Harald Berchtold. This teamwork has facilitated the advancement of research projects and helped in realizing innovative solutions in medicinal chemistry.
Conclusion
Dirk Hoerstermann exemplifies the spirit of innovation within the pharmaceutical industry. His contributions, particularly through his patent, highlight the importance of polymorphic substances in drug development, showcasing his commitment to improving healthcare through innovative science.